S Korea's Mirae Asset Venture co-leads $18m funding in KAHR Medical

S Korea's Mirae Asset Venture co-leads $18m funding in KAHR Medical

biopharmaceuticals. Credit: Flickr/Laurence Livermore

26 February, 2020

KAHR Medical Ltd Mirae Asset Venture Investment

Printed by Unregistered user on Sat, 12 Jul 2025 13:05:47 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

Hummingbird Bioscience secures $19m in Mirae Asset-backed Series B

Indonesia's Kredivo said to secure Series C funding from Mirae Asset Capital

Read more from Rest of Asia

Brookfield, Stonepeak and Air Liquide shortlisted for Macquarie’s $3.6b S. Korean gas firm

MUFG targets US to ramp up global securitisation business